An inexpensive repurposed drug called fluvoxamine can save the lives of COVID-19 patients and cut hospital admissions by up to 30 per cent, new research co-led by McMaster shows.
The inexpensive oral antidepressant can cut hospital admissions by up to 30 per cent, says a study co-led by researcher Ed Mills.
The study will evaluate the drugs’ effectiveness in preventing COVID-19 disease progression, and researchers say the results could be known in as little as two to three months.
McMaster logo
McMaster logo
